New Haven Pharmaceuticals intends to establish commercial and development partnerships with pharmaceutical companies and/or contract sales organizations to develop, market and sell its products once regulatory approvals are obtained. The company's products are currently planned to l be marketed to primary care physicians and cardiologists.

For further information, please contact:

Harry H. Penner, Jr.
Executive Chairman, NHP
(203) 676-3676